
Orthofix Medical's M6-C Artificial Cervical Disc Receives FDA's Approval for Cervical Disc Degeneration
Shots:
- The approval is based on Investigational Device Exemption (IDE) study assessing M6-C artificial cervical disc vs anterior cervical discectomy and fusion (ACDF) in patients with cervical radiculopathy with/out cord compression at between C3 to C7
- The US IDE study results @24months: 90.5% improvement in Neck Disability Index; improvement in arm & neck pain score (91.2% & 90.5% vs 77.9% & 79.9%); administration of analgesic @surgery (80.6% vs 85.7%) @24mos. (14.0% vs 38.2%); need of additional surgery (1.9% vs 4.8%)
- The M6-C artificial cervical disc is used to replace an intervertebral disc- restore physiological motion in spine- mimics the anatomical structure & capable to absorb shocks and has received EU’s CE Mark with up to 45-000 implants
Ref:Orthofix Medical | Image: Ortho Spine
Click here to read the full press release

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com